International Clinical Trial: A study of JNJ-90301900 in combination with chemoradiation followed by consolidation immunotherapy for non-small cell lung cancer (NSCLC)

Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ISRCTN81039232) titled 'A study of JNJ-90301900 in combination with chemoradiation followed by consolidation immunotherapy for non-small cell lung cancer (NSCLC)' on July 7.

Study Type: Interventional

Study Design: Interventional randomized parallel group controlled trial (Safety, Efficacy)

Primary Sponsor: Johnson & Johnson (Netherlands)

Condition: Locally advanced and unresectable Stage III non-small cell lung cancer Cancer

Intervention: Experimental: Part 1: Cohort A and Cohort B Participants will receive JNJ-90301900 injected intratumorally and/or intranodally (cohort A: 22% gross tumor volume [GTV] and cohort B: 33% GTV) alo...